Brown Brothers Harriman & Co’s NeoGenomics NEO Stock Holding History

Brown Brothers Harriman & Co’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-308	Closed	-$3.62K	–	1872
2025 Q4	$3.62K	Buy	+308	New	+$3.32K	﹤0.01%	1594
2022 Q4	–	Sell	-1,017	Closed	-$9K	–	1417
2022 Q3	$9K	Buy	1,017 +686	+207%	+$6.81K	﹤0.01%	1177
2022 Q2	$3K	Buy	+331	New	+$3.16K	﹤0.01%	1207
2020 Q2	–	Sell	-217	Closed	-$6K	–	1119
2020 Q1	$6K	Sell	217 -442	-67%	-$13.2K	﹤0.01%	774
2019 Q4	$19K	Hold	659	–	–	﹤0.01%	807
2019 Q3	$13K	Buy	+659	New	+$15.5K	﹤0.01%	854

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Brown Brothers Harriman & Co's NEO Position: Q1 2026 in Review

Brown Brothers Harriman & Co sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 308 shares — an estimated $3.62K sold.

Brown Brothers Harriman & Co first reported a position in NEO in Q3 2019 and held it in 6 quarters. The position peaked at $19K in Q4 2019. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

Brown Brothers Harriman & Co reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
Brown Brothers Harriman & Co sold 308 NeoGenomics shares in Q1 2026, an estimated $3.62K.
Brown Brothers Harriman & Co first reported a position in NeoGenomics in Q3 2019 and held it in 6 quarters.
Brown Brothers Harriman & Co's NeoGenomics position peaked at $19K in Q4 2019.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2026, filed 14 May 2026.